Your request to link to rcsb for PDE5A/PDE6C
- 1RKP: crystal structure of pde5a1-ibmx (10.1074/JBC.M311556200 )
- 1T9R: catalytic domain of human phosphodiesterase 5a (10.1016/J.MOLCEL.2004.07.005 )
- 1T9S: catalytic domain of human phosphodiesterase 5a in complex with gmp (10.1016/J.MOLCEL.2004.07.005 )
- 1TBF: catalytic domain of human phosphodiesterase 5a in complex with sildenafil (10.1016/J.MOLCEL.2004.07.005 )
- 1UDT: crystal structure of human phosphodiesterase 5 complexed with sildenafil(viagra) (10.1038/NATURE01914 )
- 1UDU: crystal structure of human phosphodiesterase 5 complexed with tadalafil(cialis) (10.1038/NATURE01914 )
- 1UHO: crystal structure of human phosphodiesterase 5 complexed with vardenafil(levitra) (10.1038/NATURE01914 )
- 1XOZ: catalytic domain of human phosphodiesterase 5a in complex with tadalafil (10.1016/J.STR.2004.10.004 )
- 1XP0: catalytic domain of human phosphodiesterase 5a in complex with vardenafil (10.1016/J.STR.2004.10.004 )
- 2CHM: crystal structure of n2 substituted pyrazolo pyrimidinones - a flipped binding mode in pde5 (10.1021/JM060113E )
- 2H40: crystal structure of the catalytic domain of unliganded pde5 (10.1074/JBC.M512527200 )
- 2H42: crystal structure of pde5 in complex with sildenafil (10.1074/JBC.M512527200 )
- 2H44: crystal structure of pde5a1 in complex with icarisid ii (10.1074/JBC.M512527200 )
- 2K31: solution structure of cgmp-binding gaf domain of phosphodiesterase 5 (10.1074/JBC.M801577200 )
- 2XSS: crystal structure of gafb from the human phosphodiesterase 5 (10.1002/PROT.22989 )
- 3B2R: crystal structure of pde5a1 catalytic domain in complex with vardenafil (10.1124/MOL.107.040212 )
- 3BJC: crystal structure of the pde5a catalytic domain in complex with a novel inhibitor (10.1016/J.BCP.2008.01.019 )
- 3HC8: investigation of aminopyridiopyrazinones as pde5 inhibitors: evaluation of modifications to the central ring system. (10.1016/J.BMCL.2009.06.004 )
- 3HDZ: identification, synthesis, and sar of amino substituted pyrido[3, 2b]pryaziones as potent and selective pde5 inhibitors (10.1016/J.BMCL.2009.06.012 )
- 3JAB: domain organization and conformational plasticity of the g protein effector, pde6 (10.1074/JBC.M115.647636 )
- 3JBQ: domain organization and conformational plasticity of the g protein effector, pde6 (10.1074/JBC.M115.647636 )
- 3JWQ: crystal structure of chimeric pde5/pde6 catalytic domain complexed with sildenafil (10.1038/EMBOJ.2009.284 )
- 3JWR: crystal structure of chimeric pde5/pde6 catalytic domain complexed with 3-isobutyl-1-methylxanthine (ibmx) and pde6 gamma-subunit inhibitory peptide 70-87. (10.1038/EMBOJ.2009.284 )
- 3LFV: crystal structure of unliganded pde5a gaf domain (10.1074/JBC.M110.141614 )
- 3MF0: crystal structure of pde5a gaf domain (89-518) (10.1074/JBC.M110.141614 )
- 3SHY: crystal structure of the pde5a1 catalytic domain in complex with novel inhibitors (10.1021/JM200644R )
- 3SHZ: crystal structure of the pde5a1 catalytic domain in complex with novel inhibitors (10.1021/JM200644R )
- 3SIE: crystal structure of the pde5a1 catalytic domain in complex with novel inhibitors (10.1021/JM200644R )
- 3TGE: a novel series of potent and selective pde5 inhibitor1 (10.1016/J.BMCL.2011.08.106 )
- 3TGG: a novel series of potent and selective pde5 inhibitor2 (10.1016/J.BMCL.2011.08.106 )
- 4G2W: crystal structure of pde5a in complex with its inhibitor (10.1021/JM301159Y )
- 4G2Y: crystal structure of pde5a complexed with its inhibitor (10.1021/JM301159Y )
- 4I9Z: crystal structure of the pde5a1 catalytic domain in complex with novel inhibitors (10.1016/J.BMCL.2013.06.062 )
- 4IA0: crystal structure of the pde5a1 catalytic domain in complex with novel inhibitors (10.1016/J.BMCL.2013.06.062 )
- 4MD6: crystal structure of pde5 in complex with inhibitor 5r (10.1016/J.BCP.2014.02.013 )
- 4OEW: crystal structure of the pde5a1 catalytic domain in complex with novel inhibitors (10.1021/JM5002315 )
- 4OEX: crystal structure of the pde5a1 catalytic domain in complex with novel inhibitors (10.1021/JM5002315 )
- 5JO3: pde5a for nav1.7
- 5ZZ2: crystal structure of pde5 in complex with inhibitor lw1634 (10.1021/ACS.JMEDCHEM.8B01209 )
- 6ACB: crystal structure of pde5 in complex with inhibitor lw1805 (10.1021/ACS.JMEDCHEM.8B01209 )
- 6IWI: crystal structure of pde5a in complex with a novel inhibitor (10.1021/ACS.JMEDCHEM.9B00123 )
- 6L6E: human pde5 catalytic core in complex with avanafil (10.1021/ACS.JMEDCHEM.0C00853 )
- 6VBI: crystal structure of pde5 in complex with a non-competitive inhibitor